These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The interplay between binding energy and catalysis in the evolution of a catalytic antibody. Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839 [TBL] [Abstract][Full Text] [Related]
5. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related]
6. Catalytic antibodies: evolution of protein function in real time. Lerner RA; Janda KD EXS; 1995; 73():121-38. PubMed ID: 7579971 [TBL] [Abstract][Full Text] [Related]
7. Structural basis for antibody catalysis of a disfavored ring closure reaction. Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817 [TBL] [Abstract][Full Text] [Related]
8. Critical analysis of antibody catalysis. Hilvert D Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475 [TBL] [Abstract][Full Text] [Related]
12. The immunological evolution of catalysis. Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084 [TBL] [Abstract][Full Text] [Related]
13. Structural insights into the evolution of an antibody combining site. Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069 [TBL] [Abstract][Full Text] [Related]
14. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review. Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447 [TBL] [Abstract][Full Text] [Related]
15. The structural and functional basis of antibody catalysis. Wade H; Scanlan TS Annu Rev Biophys Biomol Struct; 1997; 26():461-93. PubMed ID: 9241427 [TBL] [Abstract][Full Text] [Related]
16. Structural convergence in the active sites of a family of catalytic antibodies. Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317 [TBL] [Abstract][Full Text] [Related]
17. Antibody catalysis via strategic use of haptenic charge. Kikuchi K; Hilvert D Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376 [TBL] [Abstract][Full Text] [Related]
18. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8. Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784 [TBL] [Abstract][Full Text] [Related]
19. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746 [TBL] [Abstract][Full Text] [Related]
20. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]